Custom Search

Wednesday, August 10, 2011

New drug and first treatment and a drug for scorpion sting exclusively now available.

First specific treatment for scorpion stings is approved by US FDA, gets approval as an orphan drug.

The US FDA has now approved a new treatment for scorpion sting , a new treatment comprising of immunoglobulin against scorpion sting, name of product approved is Anascorp (Equine) Injection, it is approved as an orphan drug and its a first drug exclusively approved for Centruroides scorpions sting.

Drug is an immunoglobuline G (Ig G) prepared by sensitizing horse with scorpion venom and collecting  horse serum and digesting it with pepsin an enzyme which can digests protein,  followed by separation F(ab’)2 fragments by process of fractionation to get  immunoglobulin F(ab’)2 fragments to take care of anaphylaxis associated with horse serum which are further purified to remove any viral contaminants and lyophilized, it is a polyvalent sterile non pyrogenic preparation.( also see What is PEGylation technology )


How the drug act against scorpion sting:
Drug Anascorp contains specific immunoglobuline G (Ig G) or antibodies against scorpion venom, when it is injected intravenously in to patient who got a scorpion sting , the drug binds with scorpion venom in the blood and tissue in patient , this bound venom is then eliminated out of body easily by further protecting patients tissue and body from bad effects of scorpion sting.

Scorpion sting if left in treated may become life threatening in some patients , typically it causes breathing problem, blurred vision, muscular twitching and uncoordinated muscle movements, fluid in lungs, increased salivation, indistinct speech, difficulty in swallowing and abnormal eye movement.
The clinical study was conducted at various parts in Arizona in united states (multicenter clinical trial) where

Clinical trial : Efficacy and safety of Anascorp was evaluated in multicenter open lable blinded clinical trial across Arizona.

Most common side effect of the drug is nousia , vomiting ,pyrexia and rash.
Precautions while using Anascorp (Equine) Injection include : known anaphylaxix to horse serum, serum sickness, myalgias .

Drug is manufactured by Instituto Bioclon, S.A. de C.V., of Tlalpan, Mexico, D.F.and licenced to Rare Disease Therapeutics Inc., Franklin, TN, and distributed by Accredo Health Group Inc., Memphis, TN.


You may also like







Why Betalactam Antibiotics require a separate manufacturing aria in a pharmaceutical manufacturing company?

Chemistry behind the allergic reactions and mode of action of betalactum antibiotics

US FDA approved first oral drug to reduce Multiple Sclerosis MS relapses

US FDA limits dosage of acetaminophen to 325 mg per unit dosage form,Requires boxed warning on lables.

US FDA honours woman who rejected thalidomide and saved millions of children's from thalidomide

A new vaccine for TB which can provide protection in late stage infection.

A Pharmaceutical exceipent Beta Cyclodextrin being used in a life saving treatment

Nanoparticles of insulin in place of painful injections in treatment for diabetes patients, transdermal , nasal drug delivery systems

Corifact becomes the first drug to treat congenital deficiency of Factor XII.

Protein which is responsible for cancer spread discovered An antisense RNA treatment or a drug could be designed to treat cancer efficiently and safely.

Novel Drugs: Cancer Chemotherapy Using Nanoparticles May Reduce Harmful Side Effects.

What is Nanotechnology, its applications in medicine and pharmaceuticals, drug developments?

Pharma sales jobs Find best pharmaceutical company Job

No comments:

Posted by: Martin

How to sucessfuly activate and receive our articles on pharmaceuticals by E-Mail

Dear readers if you wish to receive our articles on pharmaceutical automatically into your email Inbox , as and when we write a new article over this website, then follow these 3 simple steps.


1.You should write your Email ID in the box provided and push the subscribe butten


2.Enter the text code that we show you in a small new browser window after you enter your email ID.

3.Log in to your email and Cheke our verification email sent by "FEEDBURNER" , there you should verify the link we send you by email.




Enter your email address get our articles by email whenever this website is updated





Delivered by FeedBurner



Join the list of our readers from Universities ,Research and Development centers Pharmaceutical Companies from all over the world.











Pharma Research Regulatory Guidelines Website
Texas Dallas, TX 75211 US
Email: editor@pharmacistspharmajournal.org Website: http://pharmacistspharmajournal.org/
Copyright © 2008-2015 all rights reserve www.pharmacistspharmajournal.org